

New Perspective: From Pandemic to Performance
As a global leader in the commercial real estate (CRE) industry, Cushman & Wakefield offers clients a new perspective on COVID-19’s impact on CRE and beyond, preparing them for what’s next.
LEARN MORE


Global Occupier Services
Helping our clients make intelligent business decisions to get maximum value from the spaces they occupy.
Learn More
Recent News
Insights

Insights • Economy
COVID-19 Impacts on Czech Real Estate
A brief weekly update on the impacts of COVID-19 pandemic on commercial real estate in Czech Republic.
Marie Baláčová • 09/04/2021

Insights • Economy
COVID-19 Impacts on Czech Real Estate
A brief weekly update on the impacts of COVID-19 pandemic on commercial real estate in Czech Republic.
Marie Baláčová • 09/04/2021

MarketBeat
Cushman & Wakefield MarketBeat reports analyse quarterly Czech Republic commercial property activity across office, retail and industrial real estate sectors including supply, demand and pricing trends at the market and submarket levels.
Marie Baláčová • 09/02/2021

Insights • Hospitality
The Hotel Investment Scene in CEE
After years of rapid and turbulent development, the CEE-6* hospitality markets were catching up with their western neighbours, in terms of both investment volumes and sophistication.
Bořivoj Vokřínek • 07/04/2020

Research
Cushman & Wakefield continuously monitors how recent developments affect the commercial real estate market.
Marie Baláčová • 26/03/2020

MarketBeat
Czech Republic MarketBeat Hospitality
Cushman & Wakefield MarketBeat Hospitality report analyse quarterly commercial property activity across hotel real estate sector in Prague, Czech Republic including supply, demand and pricing trends at the market.

Research
All the latest data for the industrial, office and investment property markets in Czech Republic on one page.
Marie Baláčová • 03/01/2019
Client Success Stories

Confidential Health Insurance Client • Healthcare
Learn More

Confidential Government Client • Government
Learn More

Boehringer Ingelheim • Life Sciences
Learn More
The C&W Advantage

- 50,000 Team Members
- $7.8 billion 2020 Revenue
- 60 Countries
Cushman & Wakefield uses cookies to analyze traffic and offer our customers the best experience on this website. Close this dialog to confirm your consent, or visit this page to learn more:
Cookie Notice